Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (LUNGEVITY STUDY)

NCT07243132 is registered in ClinicalTrials.gov with GFPC Investigation as lead sponsor.

NCT NCT07243132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07243132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (LUNGEVITY STUDY)
Lead sponsor
GFPC Investigation
Phase
Observational
Overall status
Recruiting
Start date
July 2, 2025
Completion date
January 31, 2031
Enrollment
1,000 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung cancer, metastatic nsclc, metastatic small cell lung cancer